Ning L, et al. The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury. Cell Death Dis. 2021;12(8):734.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, et al. Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells. Bioanalysis. 2013;5(3):327–39.

Article  CAS  PubMed  Google Scholar 

Cheng F, et al. Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma. Cancer Med. 2021;10(18):6503–14. https://doi.org/10.1002/cam4.4156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He S, et al. Histone deacetylase inhibitor SAHA improves high salinity tolerance associated with hyperacetylation-enhancing expression of ion homeostasis-related genes in cotton. Int J Mol Sci. 2020;21(19):7105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen IC, Sethy B, Liou J-P. Recent update of HDAC inhibitors in lymphoma. Front In Cell Dev Biol. 2020;8:576391.

Article  Google Scholar 

Ojha R, et al. 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. Eur J Med Chem. 2018;150:667–77.

Article  CAS  PubMed  Google Scholar 

Banerjee S, et al. Structural exploration of tetrahydroisoquinoline derivatives as HDAC8 inhibitors through multi-QSAR modeling study. J Biomol Struct Dyn. 2020;38(5):1551–64.

Article  CAS  PubMed  Google Scholar 

Grivas P, et al. Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes. Cancer. 2019;125(4):533–40.

Article  CAS  PubMed  Google Scholar 

Wawruszak A, et al. Histone deacetylase inhibitors and phenotypical transformation of cancer cells. Cancers. 2019;11(2):148.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao T, et al. Hdac8 inhibitor alleviates transverse aortic constriction-induced heart failure in mice by downregulating Ace1. Oxid Med Cell Longev. 2022;2022:6227330.

PubMed  PubMed Central  Google Scholar 

Kishkevich A, et al. Gcn5 and Rpd3 have a limited role in the regulation of cell cycle transcripts during the G1 and S phases in Saccharomyces cerevisiae. Sci Rep. 2019;9(1):10686.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Li H. Structure-based inhibitor discovery of class i histone deacetylases (HDACs). Int J Mol Sci. 2020;21(22):8828.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woan KV, et al. Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer. Immunol Cell Biol. 2012;90(1):55–65.

Article  CAS  PubMed  Google Scholar 

Lee DY, Chiu JJ. Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium. J Biomed Sci. 2019;26(1):56.

Article  PubMed  PubMed Central  Google Scholar 

Deng R, et al. HDAC is indispensable for IFN-γ-induced B7–H1 expression in gastric cancer. Clin Epigenet. 2018;10(1):153.

Article  CAS  Google Scholar 

Herbein G, Wendling D. Histone deacetylases in viral infections. Clin Epigenet. 2010;1(1–2):13–24.

Article  CAS  Google Scholar 

Jona A, Younes A. Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma. Blood Rev. 2010;24(6):233–8.

Article  PubMed  PubMed Central  Google Scholar 

Icardi L, De Bosscher K, Tavernier J. The HAT/HDAC interplay: multilevel control of STAT signaling. Cytokine Growth Factor Rev. 2012;23(6):283–91.

Article  CAS  PubMed  Google Scholar 

Tanji N, et al. Potential of histone deacetylase inhibitors for bladder cancer treatment. Expert Rev Anticancer Ther. 2011;11(6):959–65.

Article  CAS  PubMed  Google Scholar 

Lim J, et al. SIRT2 affects primary cilia formation by regulating mTOR signaling in retinal pigmented epithelial cells. Int J Mol Sci. 2020;21(6):2240.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomes P, Fleming Outeiro T, Cavadas C. Emerging role of sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol Sci. 2015;36(11):756–68.

Article  CAS  PubMed  Google Scholar 

Wang Y, et al. SIRT2: controversy and multiple roles in disease and physiology. Ageing Res Rev. 2019;55:100961.

Article  CAS  PubMed  Google Scholar 

Zhang Y, et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 2003;22(5):1168–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan X, et al. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLoS ONE. 2014;9(12):e115401.

Article  PubMed  PubMed Central  Google Scholar 

Milazzo G, et al. Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability. Genes. 2020;11(5):556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li G, Tian Y, Zhu W-G. The roles of histone deacetylases and their inhibitors in cancer therapy. Front Cell Dev Biol. 2020;8:576946.

Article  PubMed  PubMed Central  Google Scholar 

Turunen MP, Yla-Herttuala S. Epigenetic regulation of key vascular genes and growth factors. Cardiovasc Res. 2011;90(3):441–6.

Article  CAS  PubMed  Google Scholar 

Lei X, Li XD. Editorial overview: recent advance in chemical genetics and chemical epigenetics. Current Opinion Chem Biol. 2019;51:A1–3.

Article  CAS  Google Scholar 

Singh G, Singh V, Schneider JS. Post-translational histone modifications and their interaction with sex influence normal brain development and elaboration of neuropsychiatric disorders. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2019;1865(8):1968–81. https://doi.org/10.1016/j.bbadis.2018.10.016.

Article  CAS  Google Scholar 

Wang W, Liu Y, Zhao L. Tambulin targets histone deacetylase 1 inhibiting cell growth and inducing apoptosis in human lung squamous cell carcinoma. Front Pharmacol. 2020;11:1188.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobow K, Blümcke I. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia. 2011;52(Suppl 4):15–9.

Article  CAS  PubMed